Organization: Health Canada
Year: 2022
Month: July
Request Number: A-2022-000065
Request Summary: Adverse Drug Reactions (ADRs) for Immunoglobulin (human). Report numbers: E2B_05023522, E2B_05075235, E2B_05078453, E2B_05008371, E2B_05043180, 000981354. ADRs for Agalsidase alfa. Report numbers: E2B_05049007, E2B_04983028. ADR for Lanadelumab. Report number: E2B_04978267.
Disposition: Disclosed in part
Number of pages: 174